Important output signals of the angiotensin subtype 1 receptor (AT 1 R) in vascular smooth muscle cells (VSMCs) are mediated by angiotensin II (Ang II)-stimulated transactivation of the epidermal growth factor receptor (EGF-R), which is critical for vascular hypertrophy. Ang II-induced EGF-R transactivation is mediated through cSrc, a proximal target of reactive oxygen species (ROS) derived from NAD(P)H oxidase (NOX) and is dependent on AT 1 R trafficking through caveolin1 (Cav1)-enriched lipid rafts. Underlying molecular mechanisms are incompletely understood. The nonreceptor tyrosine kinase, proto-oncogene cAbl is a substrate of Src and is a major mediator for ROS-dependent tyrosine phosphorylation of Cav1. We thus hypothesized that cAbl is important for ROS-, cSrc-, and Cav1-dependent growth-related AT 1 R signal transduction. Here we show that Ang II induces tyrosine phosphorylation of cAbl in rat VSMCs and mouse aorta, and that Ang II promotes association of cAbl with AT 1 R, both of which are Src-dependent. Pretreatment of rat VSMCs with the NOX inhibitor diphenylene iodonium or the antioxidants N-acetylcysteine or ebselen significantly inhibited Ang II-induced cAbl phosphorylation. Cell fractionation shows that both EGF-Rs and cAbl are found basally in Cav1-enriched membrane fractions. Knockdown of cAbl protein using small interference RNA inhibits Ang II-stimulated: (1) trafficking of AT 1 R into, and EGF-R out of, Cav1-enriched lipid rafts; (2) EGF-R transactivation; (3) appearance of the transactivated EGF-R and phospho-Cav1 at focal adhesions; and (4) vascular hypertrophy. These studies provide a novel role of cAbl in the spatial and temporal organization of growth-related AT 1 R signaling in VSMCs and suggest that cAbl may be generally important in signaling of G-protein coupled receptors. (Circ Res. 2005;97:829-836.)
A ngiotensin II (Ang II) is important in mediating vascular remodeling and hypertrophy in hypertension. These effects are mediated, in large part, through the G-protein coupled angiotensin subtype 1 receptors (AT 1 Rs). The growth-related outputs of the AT 1 R are dependent on the transactivation (tyrosine phosphorylation) of the epidermal growth factor receptor (EGF-R) and its activation of mitogenactivated protein kinases and Akt, which are involved in vascular smooth muscle cell (VSMC) hypertrophy. 1, 2 Many effects of Ang II are dependent on the AT 1 R stimulation of reactive oxygen species (ROS) production by NAD(P)H oxidase. [2] [3] [4] [5] EGF-R transactivation in VSMCs is mediated through the activation of cSrc, a proximal ROS-dependent event. 5 Caveolae/lipid rafts are specialized membrane microdomains where multimolecular signaling molecule complexes are compartmentalized, in part, via interacting with caveolin1 (Cav1). We showed that in VSMCs, Ang II stimulation promotes AT 1 R association with Cav1 and its trafficking into Cav1-enriched lipid rafts, events which in turn are associated contemporaneously with egress of EGF-Rs from their basal location in these fractions. 6 -8 EGF-R migration from the Cav1-enriched lipid rafts is required for the appearance of transactivated EGF-R at focal adhesions, where they colocalize with vinculin and tyrosine phosphorylated Cav1. 7 These results suggest an important role for ROS, cSrc, and phospho-Cav1 in Ang II-induced EGF-R transactivation in AT 1 Rmediated growth-related signaling events. Underlying organizing molecular mechanisms are incompletely understood.
The proto-oncogene, nonreceptor tyrosine kinase cAbl is a substrate of Src family kinases. 9, 10 cAbl is a homologue of the Ablelson murine leukemia virus and fusion mutations are involved in tumorigenesis and leukemia. 11 It contains a myristoylation site, SH2 and SH3 domains potentially mediating protein-protein interactions, and a catalytic domain. 12 It also has a large, unique C-terminus with several polyprolinerich regions, actin binding domains, and nuclear targeting and export signals. cAbl Ϫ/Ϫ mice have high intrauterine mortality and are neonatally fragile. 13 Nuclear cAbl is involved in apoptosis induced by DNA damage. 12 Cytoplasmic cAbl is activated through Src by platelet-derived growth factor or by extracellular matrix proteins and is involved in cytoskeletal remodeling. 14 Moreover, cAbl induces c-myc expression and cell growth. 10 Thus, cAbl is an important effector of Srcrelated growth factor-induced mitogenesis and actin cytoskeleton remodeling. 15 It is also activated by ROS 16 -18 and is one of the important mediators of ROS-dependent tyrosine phosphorylation of Cav1. 18 cAbl has not been implicated previously in AT 1 R signaling or for that matter in G-protein coupled signaling generally.
Here, we test the hypothesis that cAbl is important for ROS-, cSrc-, and Cav1-dependent growth-related AT 1 R signal transduction. We show that Ang II induces tyrosine phosphorylation of cAbl in rat VSMCs and mouse aorta, and that Ang II promotes cAbl association with AT 1 R, both of which are Src-dependent. Ang II-induced cAbl activation is ROS-dependent. We noted that cAbl has a Cav1 binding consensus sequence and showed that it is localized basally in Cav1-enriched membrane fractions. We provide evidence that cAbl is important for Ang II-induced: (1) trafficking of AT 1 R into, and EGF-R out of, Cav1-enriched lipid rafts; (2) EGF-R phosphorylation; (3) appearance of the transactivated EGF-R and phospho-Cav1 at focal adhesions; and (4) 3 Hleucine incorporation, a surrogate for VSMC hypertrophy. These studies provide evidence for a novel role of cAbl in the spatial and temporal organization of AT 1 R signaling in VSMCs.
Materials and Methods
Materials, cell culture, infection of adenovirus, synthetic small interference RNA (siRNA) and its transfection, Ang II stimulation of the aorta of mice ex vivo and in vivo, immunofluorescence, purification of caveolae fractions, immunoprecipitation and immunoblotting, [ 3 H] leucine incorporation, and statistical analyses are in the Materials and Methods section in the online data supplement available at http://circres.ahajournals.org.
Results

Ang II Induces Tyrosine Phosphorylation of cAbl in Rat VSMC and Mouse Aorta
Western analysis revealed that cAbl is abundantly expressed in various cells and tissues including VSMCs, endothelial cells, fibroblasts, and aorta as a 145 kDa protein (supplemental Figure I ). This molecular mass of cAbl is consistent with that previously reported in other cells and tissues, whereas some cells also include a 110 kDa shorter fragment. 19 In rat VSMCs, Ang II (100 nmol/L) induced tyrosine phosphorylation of cAbl that peaked at 5 minutes and remained above baseline for up to 60 minutes ( Figure 1A ). This response was dose-dependent, with a threshold of 1 nmol/L and a maximum effect occurring at 100 nmol/L (supplemental Figure  IIA) . Furthermore, the AT 1 receptor blocker losartan significantly blocked cAbl phosphorylation (supplemental Figure  IIB ), suggesting that Ang II-stimulated cAbl phosphorylation is mediated through the AT 1 receptor. Similarly, tyrosine phosphorylation of cAbl is also observed in isolated mouse aortas exposed to Ang II (100 nmol/L) for 30 minutes ex vivo ( Figure 1B ) and in aortas of mice infused with Ang II (0.7 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ) for 24 hours, which did not induce any blood pressure increase ( Figure 1C ). We confirmed that similar phosphorylation of 145 kDa cAbl by Ang II was obtained with phospho-specific cAbl (pY412) antibody (Cell Signaling) (data not shown). Ang II stimulates cAbl phosphorylation in rat VSMCs and mouse aorta ex vivo and in vivo. A, Rat VSMCs were stimulated with Ang II (100 nmol/L) for indicated times. B, Thoracic aortae from C57BL/6J mice were stimulated with Ang II (100 nmol/L) for 30 minutes and the vessels were homogenized. C, mice were infused with [Val5]Ang II (0.7 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ) for 24 hours, and aortae were harvested. NC and PC indicate negative control (IP with nonimmune IgG) and positive control (VSMC lysates stimulated with Ang II), respectively. For A, B, and C, cAbl phosphorylation was measured by immunoprecipitation with cAbl antibody and immunoblotting with phosphotyrosine (pTyr) antibody. Immunoblotting with cAbl is shown as a loading control. The graphs represent averaged data (nϭ3), corrected for total cAbl loading, expressed as change over basal. *PϽ0.05 for Ang II-induced change vs vehicle alone.
cSrc Mediates Ang II-Induced cAbl Tyrosine Phosphorylation
We examined upstream pathways mediating cAbl tyrosine phosphorylation by Ang II. The Src family kinase inhibitor PP1 blocked Ang II-induced tyrosine phosphorylation of cAbl, but inhibition of phosphatidylinositol-3-kinase by wortmannin or LY294002 or of protein kinase C by GF109203X did not do so ( Figure 2A ). Ang II-induced cAbl phosphorylation was significantly inhibited by KI-cSrc overexpression, whereas a control virus, Ad.LacZ, had no effect. These results are consistent with the notion that cSrc is an upstream mediator for cAbl activation by Ang II ( Figure 2B ).
Ang II Promotes cSrc-Mediated Association of cAbl With AT 1 R
To gain insight into the mechanisms involved in the cSrcdependent AT 1 R activation of cAbl, rat VSMCs were stimulated with Ang II (100 nmol/L) and lysates were immunoprecipitated with AT 1 R antibody and immunoblotted with cAbl or cSrc antibody. As shown in Figure 3A , AT 1 R binds at relatively low levels to cSrc and cAbl basally. Ang II stimulation increased association of cAbl with AT 1 R, which was detectable at 2 minutes and peaked at 5 minutes, and then continued at a similar level for at least 60 minutes. Reprobing of these blots with anti-phospho-cAbl (pY412) antibody reveals that phospho-cAbl associates with AT 1 R within 5 minutes, which is cotemporaneous with the Ang II-induced increase in cAbl phosphorylation, raising the possibility that the nonphosphorylated form of cAbl binds initially to the AT 1 R/cSrc complex within 2 minutes after stimulation. cSrc was also recruited to the AT 1 R complex within 2 minutes, peaked at 5 minutes, and returned toward baseline within 15 minutes. Ang II-stimulated formation of an AT 1 R/cSrc/cAbl complex was inhibited by PP1 ( Figure 3B ). Association of cSrc and cAbl with AT 1 R was further evaluated by converse experiments: Immunoprecipitating with cSrc ( Figure 3C ) or cAbl antibody (data not shown) and immunoblotting with AT 1 R antibody. The results are consistent with a scenario in which Ang II promotes formation of AT 1 R/cSrc/cAbl complexes in a Src kinase-dependent manner and shows that these interactions may contribute to the cSrc-dependent phosphorylation of cAbl.
ROS Mediate Tyrosine Phosphorylation of cAbl by Ang II
cSrc is an important target of ROS in Ang II signaling. 5 Thus, we examined the role of ROS in cAbl phosphorylation by Figure 4A ) and dosedependently (supplemental Figure IIIA) increased cAbl phosphorylation, which was inhibited by PP1 ( Figure 4B ). Furthermore, pretreatment with various ROS inhibitors (diphenylene iodonium [DPI] , an inhibitor of flavincontaining enzymes; N-acetylcysteine [NAC]; and ebselen, a glutathione peroxidase mimetic) caused significant inhibition of tyrosine phosphorylation of cAbl by Ang II ( Figure 4C ). We also confirmed that polyethylene glycol (PEG)-catalase inhibits Ang II-induced intracellular H 2 O 2 production, as measured by DCF fluorescence (supplemental Figure IIIB) , as well as cAbl phosphorylation ( Figure 4D ), suggesting that Ang II-induced cAbl activation is mediated through H 2 O 2 .
Knockdown of cAbl Protein by siRNA Inhibits EGF-R Transactivation by Ang II
To determine the functional role of cAbl in Ang II-induced EGF-R transactivation, we designed and tested several siRNA sequences targeting various regions of cAbl (siRNA 1 to 5) (see online supplement Materials and Methods). Transfection of cAbl siRNA in rat VSMCs showed that one of them (cAbl siRNA-1) almost completely knocked down cAbl protein expression without affecting the expression of the cAbl-related protein tyrosine kinase Arg or of ␣-tubulin ( Figure 5A ). We thus used this specific cAbl siRNA for the subsequent functional analysis of cAbl. cAbl siRNA significantly inhibited Ang II-induced transactivation of EGF-R without affecting EGF-induced EGF-R autophosphorylation ( Figure 5B ), indicating that cAbl is involved in the pathways linking AT 1 R to EGF-R transactivation.
cAbl Is Involved in Ang II-Stimulated AT 1 R Trafficking Into, and Egress of EGF-R From, Cav1-Enriched Lipid Rafts
To determine the role of cAbl in AT 1 R trafficking into Cav1-enriched lipid rafts, which is required for Ang II- induced EGF-R transactivation, 7 we isolated Cav1-enriched microdomains. 20 In unstimulated rat VSMCs, AT 1 R was localized in heavy membrane fractions (fractions 10 to 13), but not in the buoyant, light-density Cav1-enriched fractions (fractions 3 to 4) (supplemental Figure IV) . Ang II stimulation for 5 minutes promoted migration of AT 1 R from heavy membrane fractions into Cav1-enriched fractions, contemporaneously with the egress of EGF-R from these membranes ( Figure 6 ). A trafficking of both receptors was significantly inhibited by cAbl siRNA (Figure 6B and 6C) . Moreover, cAbl and cSrc were present in both heavy and Cav1-enriched membrane fractions basally (supplemental Figure IV) . Ang II stimulation partially reduced the amount of both proteins in the heavy fractions, which was associated with an increase in cAbl protein in Cav1-enriched light membrane fractions (1.9Ϯ0.1 fold increase, nϭ3; Figure 6B ) and coimmunoprecipitation of cAbl with Cav1 (data not shown). The amount of phospho-cSrc (pY418) in Cav1-enriched fractions was also increased after Ang II stimulation (data not shown).
cAbl Is Involved in the Colocalization at Focal Adhesions of Tyrosine Phosphorylated Cav1 and Transactivated EGF-R
Cav1 is tyrosine phosphorylated by cAbl. 18 We previously demonstrated that Ang II-induced tyrosine-phosphorylated Cav1 (pY14-Cav1) is localized in focal adhesions together with transactivated EGF-R. 7 Thus, we examined the role of cAbl in this response. Immunofluorescence studies showed that, on stimulation with Ang II, phospho-EGF-R colocalized with pY14-Cav1 ( Figure 7) and with vinculin, a marker protein of focal adhesions (data not shown). The staining of these proteins is reproducible; more than 90% of cells show the identical patterns. In rat VSMCs transfected with cAbl siRNA, Ang II-stimulated, but not basal, staining of pY14-Cav1 and of activated EGF-R in focal adhesions were markedly reduced. The decrease in Ang II-stimulated pY14-Cav1 level by cAbl siRNA was further confirmed by Western blot analysis (data not shown).
cAbl Is Involved in Ang II-Stimulated VSMC Hypertrophy
To gain insights into the functional role of cAbl in AT 1 R signaling, we examined whether cAbl is involved in Ang II-stimulated VSMC hypertrophy. As shown in Figure 8 , cAbl siRNA significantly inhibited Ang II-stimulated [ 3 H]leucine incorporation without affecting basal levels. The trypan blue exclusion test for cell viability indicated that cells transfected with cAbl siRNA were Ͼ98% viable. Thus, cAbl plays an important role for Ang II-induced VSMC hypertrophy.
Discussion
The present study demonstrates that Ang II activates the cAbl tyrosine kinase in rat VSMCs and mouse aorta and promotes the cSrc-dependent association of cSrc, cAbl, and AT 1 R. Ang II-induced cAbl tyrosine phosphorylation is mediated through ROS-dependent cSrc activation. Furthermore, cAbl plays an important role for AT 1 R trafficking into Cav1-enriched lipid rafts, EGF-R transactivation, and tyrosine phosphorylation of Cav1, as well as the colocalization of pEGF-R and pY14Cav1 at focal adhesions. Collectively, these cAbl-dependent responses contribute to regulation of Ang II-induced [ 3 H]leucine incorporation into rat VSMCs. cAbl is activated by growth factors 9,10,21 and by oxidative stress. 16 -18 Here, we show that cAbl is expressed in various cells, including VSMCs, endothelial cells, and fibroblasts. Ang II stimulation induces tyrosine phosphorylation of cAbl in rat VSMCs and in the aorta of mice ex vivo and in vivo (independent of pressor effects) (Figure 1 ). To our knowledge, this demonstration in VSMCs of the phosphorylation of cAbl by AT 1 R or, more generally, by any G-protein-coupled receptor agonist, is novel. Phosphorylated tyrosine on cAbl may provide binding sites for SH3 domain containing targets of cAbl, including CrkII, Nck, and Grb2, 15 thereby activating downstream signaling cascades. The findings in the aorta support the physiological importance of cAbl in Ang II signaling in vivo as inferred by the in vitro cell culture data. Because cAbl is also expressed in endothelial cells and fibroblasts (supplemental Figure I ), we cannot eliminate the possible contribution of these cells to total cAbl phosphorylation in mouse aorta. This point requires further investigation.
Although the upstream signaling mechanisms responsible for cAbl activation have not been fully elucidated in other systems, a roles for cSrc and other Src family kinases such as Fyn have been documented. 9, 10 We demonstrate that both the Src-family kinase inhibitors PP1 and KI-Src almost completely inhibited Ang II-induced phosphorylation of cAbl in rat VSMCs (Figure 2) . Thus, cSrc appears to be the major Src family kinase involved here. Activated Src family kinases directly phosphorylate tyrosine residues in the kinase domain of cAbl, which correlates with enhanced activity. 9 Phospholipase C␥ (PLC␥) is required for cAbl activation by plateletderived growth factor. 22 cSrc is involved in PLC␥ activation by Ang II. 23 Thus, it is possible that an AT 1 R/cSrc/PLC␥ pathway may contribute to cAbl activation by Ang II in VSMCs.
AT 1 R slightly associates with cSrc and cAbl basally, and Ang II stimulation rapidly promotes the enhanced recruitment of cSrc and cAbl to a complex with AT 1 R, which is inhibited by PP1 ( Figure 3 ). Furthermore, non-phospho-cAbl appears to bind initially to AT 1 R (within 2 minutes), and subsequently phosphorylated cAbl appears in the AT 1 R complex ( Figure  3A) . We also found that cAbl siRNA does not affect cSrc binding to the receptor (supplemental Figure V) . These results suggest that cSrc is pivotal in Ang II-induced formation of the AT 1 R/cSrc/cAbl complex, which possibly facilitates cAbl phosphorylation. Our results contrast with a previous report that cSrc does not bind to AT 1 R in VSMCs. 24 This discordance may be attributable to differences in experimental conditions (purified cSrc and AT 1 R or cell culture conditions, etc) or specificity of AT 1 R antibodies.
cAbl interacts directly with various receptors, including the Trk nerve growth factor receptor, EphB2, and N-methyl-Daspartic acid receptors through the SH2 or SH3 domains of cAbl. 21, [25] [26] [27] Of note, another nonreceptor tyrosine kinase (JAK2) binds directly to the AT 1 R by a mechanism requiring the tyrosine phosphatase SHP-2. 28 Also, in transfection experiments, EGF-R associates transiently with AT 1 R through an SHP-2-dependent mechanism. 29 In VSMCs, Ang II stimulation promotes association of SHP-2 with AT 1 R. 28 Thus, it is possible that SHP-2 may function in VSMCs as an AT 1 R scaffold to form the AT 1 R/cSrc/cAbl complex. Detailed analysis of cAbl-AT 1 R association is an objective of future studies.
We reported that production of H 2 O 2 is observed within 1 minute of Ang II stimulation. 3 We show that Ang II-induced cAbl tyrosine phosphorylation is significantly inhibited by various ROS inhibitors, including DPI, NAC, ebselen, and PEG-catalase (Figure 4 ), suggesting an essential role of NAD(P)H oxidase-derived H 2 O 2 in this response. Redox sensitivity of cAbl phosphorylation was further confirmed by the finding that exogenous H 2 O 2 increased cAbl phosphorylation (Figure 4 and supplemental Figure IIIA) , which is consistent with other reports. 16 -18 The relatively slow activation of cAbl phosphorylation by exogenous H 2 O 2 is possibly attributable to barriers to diffusion or to varying antioxidant capacity in different cellular compartments. In contrast, receptor-mediated ROS production may be compartmental- ized and may act on preformed, primed AT 1 R containing cSrc/cAbl complex in appropriate agonist-induced spatial conformations, thereby activating cSrc and cAbl in close proximity to the receptor more rapidly and efficiently. Given that H 2 O 2 -induced cAbl phosphorylation is inhibited by PP1 ( Figure 4B ) and that cSrc is a very proximal target of ROS in Ang II signaling, 5 redox-sensitivity of cAbl may be conferred through ROS-dependent activation of cSrc. SHP-2 is a negative regulator of Ang II-induced cSrc activation in VSMCs, 30 and phosphatase activity of SHP-2 is inhibited by ROS. 31 Thus, evidence supports the notion that Ang IIinduced cAbl phosphorylation in VSMCs is mediated through ROS-dependent cSrc activation and may also involve SHP-2.
To explore downstream targets of cAbl in AT 1 R signaling, we examined whether cAbl is involved in Ang II-induced EGF-R transactivation. Knockdown of endogenous cAbl using siRNA significantly inhibited Ang II-induced EGF-R tyrosine phosphorylation without affecting EGF-mediated EGF-R phosphorylation ( Figure 5 ). Thus, cAbl is involved selectively in the pathways linking AT 1 R to the EGF-R, but does not appear to be involved in EGF activation of its receptor's tyrosine kinase. We showed previously, using detergent-free membrane fractionation, that Ang II promotes not only AT 1 R trafficking into Cav1-enriched/lipid rafts but also egress of EGF-Rs from these microdomains. These events seem to be required for Ang II transactivation of EGF-R and downstream signal generation. 7 We noted that cAbl contains 2 Cav1 consensus binding sequences ( 312 YI-ITEFMTY 320 and 423 YAFGVLLW 430 ) and found that cAbl is localized basally in Cav1-enriched fractions, and its concentration is enhanced after Ang II stimulation ( Figure 6 ). cAbl siRNA inhibits Ang II-stimulated trafficking of AT 1 R into, and EGF-R out of, Cav1-enriched lipid rafts. As shown previously, Ang II promotes AT 1 R association with Cav1, 6 and Cav1 siRNA blocks AT 1 R trafficking into Cav1-enriched fractions. 8 We also show that AT 1 R, cSrc, and cAbl are localized, at least in part, in the heavy membrane fractions basally, and the amounts of these proteins are decreased after Ang II stimulation (supplemental Figure IV) at the time in which AT 1 R migrates into the lipid rafts fractions ( Figure 6) . Thus, our current model is consistent with the possibilities that the initial AT 1 R/cSrc/cAbl interaction and subsequent cSrc-dependent cAbl phosphorylation by Ang II may take place in the heavy membrane fractions and that active AT 1 R/cSrc/cAbl complexes move into Cav1-enriched fractions. Ang II promotes association of Cav1 with AT 1 R 6 and cAbl (present study), and Cav1 siRNA inhibits Ang IIinduced cSrc and cAbl binding to the AT 1 R, as well as cAbl phosphorylation (unpublished observations, 2005). Thus, Cav1 may function as a scaffold to organize and target AT 1 R/cSrc/cAbl complexes into the Cav1-enriched/lipid rafts.
Cav-1 is a major tyrosine phosphorylation substrate of cAbl. 18 We showed that Ang II-induced egress of EGF-R from Cav-1 enriched lipid rafts in VSMCs is required for the appearance of transactivated EGF-R at focal adhesions, where it colocalizes with pY14-Cav1. 7 cAbl siRNA inhibits Ang II-induced colocalization of phosphor-EGF-Rs and pY14-Cav1 at focal adhesions. Western analysis confirmed that Ang II-induced tyrosine phosphorylation of Cav1 is inhibited by cAbl siRNA. Cav1 is tyrosine phosphorylated by various growth factors, including EGF 32 and VEGF. 33, 34 Phospho-Cav1 interacts with the scaffold Grb7 35 and Csk, a negative regulator for Src, 36 suggesting that pY14-Cav1 functions in organizing phosphotyrosine-binding molecules involved in growth factor-mediated signaling. Lewis et al 14 reported that cAbl is involved in signal transduction activated by integrins. Thus, cAbl-dependent localization of transactivated EGF-R and pY14-Cav1 at focal adhesions, a major site of tyrosine kinase signaling, 37 indicates an important role of cAbl in growth-related AT 1 R signaling in VSMCs. The site(s) at which the Cav1 and EGF-R phosphorylation events initially occur are not known, but they could be at the focal adhesions. This point requires further investigation.
Proposed functional roles for cAbl include oncogenesis, apoptosis during DNA damage, actin cytoskeleton regulation, 9, 12, 15 and growth factor-induced DNA synthesis. 10 The present study reveals a new function of cAbl in AT 1 R signaling in VSMCs. We show that cAbl siRNA significantly inhibits Ang II-stimulated increase in [ 3 H]leucine incorporation, indicating that this kinase is involved in VSMC hypertrophy. The partial inhibition of cAbl siRNA may be attributable to the facts that Ang II-induced vascular hypertrophy is mediated through both ROS-dependent Akt and ROSindependent ERK1/2 pathways and that cAbl siRNA inhibits Akt, but not ERK1/2, phosphorylation by Ang II (unpublished observation, 2005). The mechanisms by which cAbl siRNA inhibits Ang II-induced VSMC hypertrophy may be, at least in part, related to its inhibition of phosphorylation of EGF-R and Cav1 in focal adhesions, as transactivated EGF-R 38 and Cav1 39 are important in Ang II-induced increases in protein synthesis in VSMCs.
As noted, cAbl is expressed within both the cytosol and nucleus. The inhibitory effect of cAbl siRNA on early signaling events activated by Ang II may reflect the role of cytoplasmic cAbl in AT 1 R-induced vascular hypertrophy. We cannot exclude possible contributions of nuclear cAbl in this response, which is the subject of future investigation.
Imatinib (STI571, Glivec), a relatively selective inhibitor of the Bcr-Abl tyrosine kinase, inhibits Ang II infusioninduced hypertrophy in rat mesenteric arteries in vivo, 40 as well as diabetes-associated atherosclerosis in aorta of apolipoprotein E Ϫ/Ϫ mice. 41 Atherosclerosis in this model is highly dependent on AT 1 R. 42 Thus, these results inferentially associating cAbl with Ang II/AT 1 R signaling are supported by our results that cAbl is a major mediator of Ang II responses in VSMCs.
In summary, we demonstrated that cAbl is activated by Ang II in rat VSMCs and mouse aortae and that Ang II stimulation promotes association of cAbl with AT 1 R in a cSrc-dependent manner. Furthermore, Ang II-induced cAbl activation is ROS-dependent. We also found that cAbl is involved in Ang II-stimulated: (1) AT 1 R trafficking into Cav1-enriched fractions; (2) egress of EGF-R from these microdomains; (3) appearance of transactivated EGF-R and phosphorylated Cav1 at focal adhesions; and (4) VSMC hypertrophy. These findings suggest a novel role of cAbl in the spatial and temporal organization of ROS-sensitive AT 1 R signaling in VSMCs.
